Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from NovoCare-a
Because of these overlapping protections, it will likely be many years before a true generic version of tirzepatide becomes available
The drug was originally used to treat diabetes
Do not mix semaglutide and insulin in the same syringe
Price Range: Research-chemical vendors typically price a 2 mg vial around $47-65, with bulk-order discounts bringing the per-vial cost down to roughly $24
Statements made within this article have not been evaluated by regulatory authorities
